A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection. AIDS Clinical Trials Group 330 Team.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples